TRUP Stock Cash Flow Statements

Trupanion Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Trupanion Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30

operating activities
net income	9,413,000	-1,483,000	1,656,000	1,425,000	-5,862,000	-6,852,000	-2,163,000	-4,036,000	-13,714,000	-24,780,000	-9,285,000	-12,914,000	-13,618,000	-8,855,000	-7,042,000	-6,819,000	-9,221,000	-12,448,000	-3,502,000	-2,558,000	1,353,000	-1,133,000	636,000	782,000	-1,931,000	-1,296,000	-275,000	1,205,000	-377,000	-1,480,000	-838,000	406,000	411,000	-1,482,000	-1,723,000	-1,637,000	-964,000	-2,572,000	-3,001,000	-4,643,000	-4,625,000	-4,936,000	-4,276,000	-8,509,000
adjustments to reconcile net income to cash from operating activities:
depreciation and amortization	3,962,000	3,791,000	3,924,000	4,381,000	4,376,000	3,785,000	3,029,000	2,990,000	3,253,000	3,202,000	2,897,000	2,600,000	2,707,000	2,717,000	2,770,000	2,944,000	3,158,000	3,093,000	2,301,000	1,666,000	1,723,000	1,381,000	1,274,000	1,181,000	1,564,000	1,613,000	1,485,000	1,136,000	964,000	927,000	1,024,000	1,095,000	1,077,000	1,036,000	1,229,000	1,093,000	739,000	785,000	742,000	671,000	563,000	566,000	440,000	505,000
stock-based compensation expense	9,456,000	9,830,000	8,294,000	8,340,000	8,646,000	8,152,000	7,301,000	6,892,000	6,637,000	12,331,000	8,567,000	8,643,000	8,634,000	7,549,000	6,808,000	6,443,000	6,527,000	8,448,000	2,602,000	2,430,000	2,227,000	1,653,000	1,771,000	1,845,000	1,873,000	1,357,000	1,222,000	1,299,000	1,286,000	968,000	855,000	895,000	888,000	781,000	731,000	776,000	743,000	696,000	653,000	749,000	897,000	703,000	890,000	2,001,000
realized gain on nonmonetary exchange of preferred stock investment
other	602,000	349,000	-1,295,000	-135,000	-116,000	-202,000	2,481,000	-549,000	-188,000	-397,000	1,023,000	102,000	5,000	-79,000	-996,000	-386,000	-315,000	-230,000	35,000	16,000	29,000	73,000	-38,000	46,000	100,000	-3,000	-3,000	-275,000	15,000	23,000	-626,000	187,000	-41,000	97,000	-172,000	179,000	30,000	9,000	2,000	22,000	3,000	-116,000
changes in operating assets and liabilities:
accounts and other receivables	-2,050,000	-15,965,000	15,303,000	-3,794,000	-7,508,000	-10,718,000	10,153,000	-12,409,000	-17,337,000	-15,847,000	-8,034,000	-19,821,000	-15,312,000	-23,815,000	-7,397,000	-17,977,000	-21,991,000	-18,805,000	-5,204,000	-11,966,000	-14,405,000	-11,697,000	-4,190,000	-6,642,000	-6,046,000	-5,894,000	344,000	-3,424,000	-4,242,000	-3,926,000	-55,000	-3,196,000	-3,596,000	-3,372,000		-1,029,000
prepaid expenses and other assets	-380,000	-204,000	817,000	101,000	2,010,000	287,000	854,000	452,000	552,000	-3,765,000	-807,000	-1,599,000	-761,000	-2,060,000	-1,133,000	170,000	-761,000	-1,331,000	-860,000	-1,535,000	-249,000	-195,000	-707,000	-714,000	664,000	325,000	-2,079,000	3,519,000	-3,939,000	-129,000	118,000	-114,000	36,000	-219,000		-246,000
accounts payable, accrued liabilities, and other liabilities	-537,000	1,527,000	2,434,000	1,377,000	3,404,000	-5,131,000	5,476,000	2,632,000	-1,316,000	-5,148,000	2,388,000	45,000	2,509,000	-1,806,000	4,443,000	5,225,000	-907,000	35,000	3,349,000	6,086,000	-806,000	1,322,000	1,304,000	1,363,000	187,000	1,256,000	682,000	1,282,000	1,657,000	910,000	897,000	1,209,000
reserve for veterinary invoices	-1,710,000	2,407,000	-4,841,000	-3,934,000	-1,650,000	-885,000	1,788,000	5,258,000	7,833,000	4,606,000	4,164,000	3,061,000	-1,785,000	-1,213,000	914,000	2,984,000	5,691,000	1,179,000	-30,000	4,428,000	1,439,000	1,825,000	1,872,000	1,042,000	1,067,000	1,078,000	1,956,000	191,000	550,000	743,000
deferred revenue	4,052,000	15,712,000	-7,889,000	7,534,000	3,556,000	13,998,000	-11,412,000	10,168,000	10,875,000	22,936,000	106,000	17,584,000	14,491,000	23,972,000	6,789,000	13,640,000	15,632,000	18,324,000	5,273,000	11,239,000	13,539,000	9,695,000	2,610,000	5,841,000	5,444,000	5,523,000	332,000	2,472,000	3,620,000	4,041,000	92,000	2,146,000	2,711,000	4,218,000	319,000	795,000	608,000	676,000	469,000	561,000	420,000	329,000	54,000	520,000
net cash from operating activities	15,025,000	15,964,000	23,702,000	15,295,000	6,856,000	2,434,000	17,507,000	11,398,000	-3,405,000	-6,862,000	1,019,000	-2,299,000	-3,130,000	-3,590,000	5,156,000	6,224,000	-2,187,000	-1,735,000	3,964,000	9,806,000	4,850,000	2,924,000	4,532,000	4,744,000	2,922,000	3,959,000	3,664,000	7,405,000	-466,000	2,077,000	2,977,000	3,008,000	1,824,000	1,857,000	3,438,000	1,308,000	1,558,000	-1,298,000	-657,000	-872,000	-3,988,000	-4,908,000	-1,101,000	-3,265,000
capex	-3,483,000	-1,125,000	-1,808,000	-1,981,000	-3,022,000	-2,371,000	-3,824,000	-4,978,000	-4,650,000	-3,941,000	-5,992,000	-3,217,000	-3,947,000	-2,608,000	192,000	-2,778,000	-3,092,000	-2,130,000	248,000	-933,000	-1,825,000	-1,141,000	271,000	-2,229,000	-406,000	-737,000	-1,139,000	-53,474,000	-1,905,000	-312,000	-1,025,000	-804,000	-802,000	-462,000	-395,000	-456,000	-437,000	-653,000	-1,078,000	-1,172,000	-1,054,000	-1,590,000	-1,620,000	-1,745,000
free cash flows	11,542,000	14,839,000	21,894,000	13,314,000	3,834,000	63,000	13,683,000	6,420,000	-8,055,000	-10,803,000	-4,973,000	-5,516,000	-7,077,000	-6,198,000	5,348,000	3,446,000	-5,279,000	-3,865,000	4,212,000	8,873,000	3,025,000	1,783,000	4,803,000	2,515,000	2,516,000	3,222,000	2,525,000	-46,069,000	-2,371,000	1,765,000	1,952,000	2,204,000	1,022,000	1,395,000	3,043,000	852,000	1,121,000	-1,951,000	-1,735,000	-2,044,000	-5,042,000	-6,498,000	-2,721,000	-5,010,000
investing activities
purchases of investment securities	-101,125,000	-40,875,000	-26,118,000	-26,126,000	-62,056,000	-19,193,000	-56,547,000	-29,458,000	-45,136,000	-34,795,000	-147,346,000	-78,292,000	-24,476,000	-22,892,000	-33,384,000	-18,915,000	-31,216,000	-12,157,000	-21,314,000	-17,422,000	-14,971,000	-11,579,000	-20,014,000	-13,270,000	-14,872,000	-17,350,000			-13,246,000	-7,140,000	-11,216,000	-5,809,000	-9,723,000	-5,172,000	-15,624,000	-4,769,000	-7,264,000	-3,959,000	-8,718,000	-5,016,000	-7,860,000	-3,206,000
maturities and sales of investment securities	61,022,000	33,242,000	45,886,000	26,089,000	36,673,000	19,005,000	42,905,000	29,713,000	43,859,000	73,793,000	134,718,000
purchases of property, equipment, and internal-use software	-2,976,000	-1,928,000	-1,858,000	-1,913,000	-2,880,000	-3,065,000	-3,970,000	-4,391,000	-4,735,000	-5,184,000
net cash from investing activities	-42,467,000	-8,973,000	18,457,000	-1,460,000	-27,717,000	-2,737,000	-17,447,000	-3,299,000	-5,529,000	33,914,000	-30,552,000	-11,827,000	-10,886,000	-14,251,000	-20,106,000	-13,171,000	-14,034,000	-4,602,000	-58,168,000	-9,701,000	-912,000	-7,966,000	-5,217,000	-9,210,000	-4,079,000	-9,502,000	-16,622,000	-57,201,000	-4,796,000	-2,832,000	-4,623,000	-2,635,000	-1,325,000	-4,473,000	-1,417,000	-2,047,000	-2,098,000	-946,000	-3,305,000	-3,174,000	-2,893,000	-551,000	-4,697,000	-6,972,000
financing activities
repayment of debt financing	-15,187,000	-338,000				-338,000	-337,000	-338,000	-435,000	-607,000																	0																0
proceeds from exercise of stock options	303,000	1,024,000	23,000	258,000	99,000	372,000	1,374,000	628,000	513,000	140,000	706,000	413,000	571,000	600,000	551,000	698,000	1,120,000	1,238,000	1,717,000	2,629,000	1,108,000	559,000	727,000	629,000	965,000	661,000	729,000	1,216,000	1,175,000	481,000	463,000	435,000			1,009,000	951,000	1,299,000	486,000	421,000	113,000	434,000	367,000	50,000	115,000
shares withheld to satisfy tax withholding	-773,000	-915,000	-1,129,000	-802,000	-343,000	-245,000	-240,000	-272,000	-171,000	-853,000	-579,000	-850,000	-632,000	-2,298,000	-1,002,000	-979,000	-870,000	-1,881,000	-459,000	-215,000	-120,000	-321,000	-57,000	-1,363,000	-50,000	-197,000	0
net cash from financing activities	-15,887,000	-459,000	-1,674,000	-1,039,000	-958,000	-286,000	569,000	24,840,000	-93,000	33,810,000	14,682,000	-710,000	-5,994,000	52,765,000	-451,000	-281,000	250,000	-643,000	163,573,000	4,892,000	-1,521,000	3,904,000	4,670,000	2,243,000	1,738,000	5,393,000	5,552,000	-11,059,000	70,971,000	5,765,000	2,161,000	17,000	2,008,000	895,000	1,720,000	3,254,000	1,225,000	1,473,000	421,000	-146,000	434,000	-14,917,000	-141,000	60,049,000
effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash	1,790,000	-52,000	-1,896,000	482,000	-150,000	-313,000	1,254,000	-906,000	-184,000	260,000	505,000	-1,268,000	-835,000	139,000	305,000	-461,000	178,000	230,000	198,000	220,000	375,000	-809,000	156,000	-129,000	176,000	220,000	-719,000	108,000	-271,000	70,000	-58,000	255,000
net change in cash, cash equivalents, and restricted cash	-41,539,000	6,480,000	38,589,000	13,278,000	-21,969,000	-902,000	1,883,000	32,033,000	-9,211,000	61,122,000	-14,346,000	-16,104,000	-20,845,000	35,063,000	-15,096,000	-7,689,000	-15,793,000	-6,750,000	109,567,000	5,217,000	2,792,000	-1,947,000	4,141,000	-2,352,000	757,000	70,000	-8,125,000	-60,747,000	65,438,000	5,080,000				-1,700,000
cash, cash equivalents, and restricted cash at beginning of period	0	199,530,000	0	0	0	170,464,000	0	0	0	84,637,000	0	0	0	100,869,000	0	0	0	146,197,000	0	0	0	30,568,000	0	0	0	27,952,000	0	0	0	26,306,000	0	0	0	24,237,000
cash, cash equivalents, and restricted cash at end of period	-41,539,000	206,010,000	38,659,000	13,278,000	-21,969,000	169,562,000	1,883,000	32,033,000	-9,211,000	145,759,000	-14,346,000	-16,104,000	-20,845,000	135,932,000	-15,096,000	-7,689,000	-15,793,000	139,447,000	109,567,000	5,217,000	2,792,000	28,621,000	4,141,000	-2,352,000	757,000	28,022,000	-8,125,000	-60,747,000	65,438,000	31,386,000	457,000	645,000	2,667,000	22,537,000
supplemental disclosures
noncash investing and financing activities:
purchases of property, equipment, and internal-use software included in accounts payable and accrued liabilities	-507,000	803,000	50,000	-68,000	-142,000	694,000	146,000	-587,000	85,000	1,243,000
purchase of intellectual property in exchange for preferred stock investment
goodwill impairment charges
cash paid in business acquisition, net of cash acquired
proceeds from debt financing, net of financing fees							0	24,972,000	0	35,130,000	14,826,000	-119,000	-32,000	54,463,000								3,744,000	4,000,000	3,000,000	967,000	5,200,000	4,242,000	-61,000	3,750,000	5,500,000	1,980,000	961,000
repurchases of common stock												-4,000
income taxes paid																																			7,000	8,000			-256,000	0	215,000	-98,000	-18,000	0
interest paid																																			61,000	64,000	44,000	-16,000	-310,000	-104,000	508,000	-249,000	-2,866,000	915,000
repayments of debt financing				-338,000
cash paid in business acquisitions, net of cash acquired
purchases of property and equipment											-5,478,000	-4,131,000	-3,926,000	-3,553,000													-1,080,000	-53,486,000	-1,378,000	-992,000	-884,000	-983,000	-802,000	-462,000	-395,000	-456,000	-437,000	-653,000	-1,078,000	-1,172,000	-1,054,000	-1,590,000	-1,620,000	-1,745,000
issuance of common stock, net of offering costs
repurchase of common stock
purchases of property and equipment included in accounts payable and accrued liabilities											-514,000	914,000	-21,000	945,000	192,000	-11,000	-205,000	753,000	248,000	340,000	-82,000	355,000	271,000	-423,000	496,000	141,000	-59,000	12,000	-527,000	680,000	-141,000	179,000
acquisition-related contingent consideration recorded as a liability
repayments of debt												-150,000
maturities of investment securities													19,013,000	12,199,000	18,803,000	8,486,000	20,102,000	10,478,000	14,249,000	9,013,000	15,704,000	5,100,000	21,538,000	6,329,000	11,690,000	10,205,000			9,715,000	5,300,000	7,494,000	4,166,000	7,841,000	3,871,000	14,670,000	3,239,000	5,638,000	3,700,000	6,600,000	3,314,000	6,021,000	4,245,000
purchases of other investments																											0
issuance of common stock for cashless exercise of warrants																							0	0	0	4,500,000	0	0	0	3,000,000
purchases of property, equipment and intangible assets																-2,767,000	-2,887,000	-2,883,000		-1,273,000	-1,743,000	-1,496,000		-1,806,000	-902,000	-878,000
borrowings from line of credit, net of financing fees																				2,478,000
repayments to line of credit																				0
acquisition of lease intangibles, related to corporate real estate acquisition																											0
other financing																							0	-23,000	-144,000	-271,000	900,000	-179,000	-140,000	-216,000
issuance of common stock for acquisition of corporate real estate																											0
gain on sale of equity method investment																															0	0
proceeds from sale of equity method investment																															0	0
proceeds from public offering of common stock, net of offering costs																											-19,000	-196,000
property and equipment acquired under financing leases
proceeds from exercise of warrants																												0
property and equipment acquired under capital lease																															0	623,000
purchases of fixed maturity investment securities
maturities of fixed maturity investment securities
property and equipment acquired under lease
other investments																															-17,000	-9,000	-43,000	-2,710,000
taxes paid related to net share settlement of equity awards
cashless exercise of common stock warrants
claims reserve																																380,000	166,000	1,093,000	1,183,000	799,000	723,000	521,000	114,000	413,000	638,000	76,000	-304,000	1,018,000
payments on financing obligations
net increase in cash, cash equivalents, and restricted cash																																645,000
payments on capital lease obligation
accounts payable																																		64,000	683,000	429,000	-260,000	-200,000	-18,000	223,000	-165,000	-387,000	298,000	76,000
accrued liabilities																																		-598,000	875,000	450,000	117,000	-1,267,000	-2,000	670,000	119,000	-736,000	949,000	30,000
other payables																																		239,000	231,000	-301,000	272,000	135,000	229,000	526,000	-612,000	-330,000	58,000	-576,000
proceeds from stock option exercises																																		1,037,000
(repayment of) proceeds from debt financing and debt financing fees																																		-40,000
payments on capital lease obligations																																		-102,000	-94,000
effect of foreign exchange rates on cash																																		21,000	-130,000	-96,000	-4,000	341,000	-191,000	-277,000	110,000	-228,000	-32,000	-31,000
increase in payables for property and equipment																																		93,000	23,000	6,000	17,000	58,000	-212,000	-39,000	716,000	-367,000	423,000	-30,000
property and equipment acquired under capital leases																																		45,000		289,000
amortization of debt discount and prepaid loan fees																																							16,000
warrant income																																											0
accounts and other receivable
prepaid expenses and other current assets																																						153,000	-37,000	-488,000	-228,000	-152,000	87,000	-335,000
equity method investment																																							0
tax withholding on restricted stock																																			0				0	-259,000	0	-384,000
proceeds from (repayment of) debt financing																																			1,000,000	3,002,000	-1,000	987,000
other financing costs
net proceeds from ipo
warrants issued in conjunction with debt issuance																																											1,000
cashless exercise of preferred stock warrants																																											0	271,000
common stock warrant reclassification to equity
net change in cash and cash equivalents																																				2,419,000	681,000	-430,000	-3,732,000	-4,469,000	-6,337,000	-20,604,000	-5,971,000
cash and cash equivalents at beginning of period																																				0	0	17,956,000	0	0	0	53,098,000	0	0
cash and cash equivalents at end of period																																				2,419,000	681,000	17,526,000	-3,732,000	-4,469,000	-6,337,000	32,494,000	-5,971,000	49,781,000
payments of capital lease obligations
accounts receivables																																						-234,000
accounts receivable																																									-998,000	75,000	702,000	-508,000
restricted cash																																											0	2,700,000
exchange of stock for equity method investment
release of restricted cash
repayment of debt financing and loan fees
proceeds from line of credit
net proceeds from initial public offering
increase in payables for deferred financing costs																																												-1,351,000
warrant expense
advance on term loan
deferred financing costs
payment on line of credit																																									0	-14,900,000
settlement of forward contract
issuance of preferred stock
purchase of treasury stock
redemption of preferred stock
proceeds from line of credit and debt financing																																											0
amortization of prepaid loan fee
amortization of debt discount																																												4,455,000
loss on disposal of equipment																																												0
income from equity method investment
net amortization on bonds																																												4,000
purchases of investment securities, held-to-maturity																																												-10,189,000
maturities of investment securities, held-to-maturity																																												4,962,000
payment of loan fee
(repayments of) proceeds from line of credit
net increase in cash and cash equivalents
exchange of stock and intangible asset for equity method investment

We provide you with 20 years of cash flow statements for Trupanion stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Trupanion stock. Explore the full financial landscape of Trupanion stock with our expertly curated income statements.

The information provided in this report about Trupanion stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.